India markets closed

Insights into the Worldwide Artificial Intelligence in Drug Discovery Industry to 2026 - Featuring Atomwise, BenevolentAI & Berg Among Others - ResearchAndMarkets.com

The "Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The global artificial intelligence (AI) in drug discovery market will reach $2.57 billion by 2026, growing by 30.3% annually over 2020-2026 despite the COVID-19 impact.

Highlighted with 86 tables and 86 figures, this 178-page report Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region.

For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global AI in drug discovery market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Topics Covered:

1 Introduction

1.1 Industry Definition and Research Scope

1.1.1 Industry Definition

1.1.2 Research Scope

1.2 Research Methodology

1.2.1 Overview of Market Research Methodology

1.2.2 Market Assumption

1.2.3 Secondary Data

1.2.4 Primary Data

1.2.5 Data Filtration and Model Design

1.2.6 Market Size/Share Estimation

1.2.7 Research Limitations

1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter's Fiver Forces Analysis

3 Segmentation of Global Market by Offering

3.1 Market Overview by Offering

3.2 Software

3.3 Service

4 Segmentation of Global Market by Technology

4.1 Market Overview by Technology

4.2 Deep Learning

4.3 Supervised Learning

4.4 Reinforcement Learning

4.5 Unsupervised Learning

4.6 Other Technologies

5 Segmentation of Global Market by Drug Type

5.1 Market Overview by Drug Type

5.2 Large-molecule Drugs

5.3 Small-molecular Drugs

6 Segmentation of Global Market by Therapeutic Area

6.1 Market Overview by Therapeutic Area

6.2 Oncology

6.3 Neurodegenerative Diseases

6.4 Cardiovascular Disease

6.5 Metabolic Diseases

6.6 Other Therapeutic Areas

7 Segmentation of Global Market by Application

7.1 Market Overview by Application

7.2 Information & Data Analysis

7.3 Drug Design

7.4 Drug Evaluation

7.5 Clinical Trials

7.6 Other Applications

8 Segmentation of Global Market by End User

8.1 Market Overview by End User

8.2 Pharmaceutical & Biotechnology Companies

8.3 Academic & Research Institutes

8.4 Contract Research Organizations

9 Segmentation of Global Market by Region

9.1 Geographic Market Overview 2019-2026

9.2 North America Market 2019-2026 by Country

9.3 European Market 2019-2026 by Country

9.4 Asia-Pacific Market 2019-2026 by Country

9.5 South America Market 2019-2026 by Country

9.6 Rest of World Market 2019-2026 by Country

10 Competitive Landscape

10.1 Overview of Key Vendors

10.2 New Product Launch, Partnership, Investment, and M&A

10.3 Company Profiles

11 Investing in Global Market: Risk Assessment and Management

11.1 Risk Evaluation of Global Market

11.2 Critical Success Factors (CSFs)

Companies Mentioned

  • Atomwise, Inc.
  • BenevolentAI
  • Berg LLC
  • Bioage
  • BIOAGE
  • Cloud Pharmaceuticals, Inc.
  • Cyclica
  • Deep Genomics
  • Envisagenics
  • Exscientia
  • Google
  • IBM Corporation
  • Insilico Medicine
  • Microsoft Corporation
  • Numedii, Inc.
  • Numerate
  • NVIDIA Corporation
  • Owkin, Inc.
  • Twoxar, Incorporated
  • Verge Genomics
  • Xtalpi, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/49m0la

View source version on businesswire.com: https://www.businesswire.com/news/home/20200603005393/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900